Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Friedlander

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Oncology|December 18, 2009
Oxaliplatin-induced lhermitte's phenomenon as a manifestation of severe generalized neurotoxicitySusanna B Park, Cindy S-Y Lin, Arun V Krishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Neuroprotection for oxaliplatin-induced neurotoxicity: what happened to objective assessment?Susanna B Park, David Goldstein, Cindy S-Y Lin, et al.
Plos One|April 16, 2011
Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicitySusanna B Park, Cindy S-Y Lin, Arun V Krishnan, et al.
Obstetrics and Gynecology|May 3, 2013
Primary surgical management with tailored adjuvant radiation for stage IB2 cervical cancerNeville F Hacker, Ellen L Barlow, James Scurry, et al.
Muscle & Nerve|February 16, 2011
Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathySusanna B Park, Cindy S-Y Lin, Arun V Krishnan, et al.
JNCI Cancer Spectrum|October 21, 2024
Impact of chemotherapy on patients with mismatch repair deficient advanced endometrial carcinomas-a meta-analysisAngelina Tjokrowidjaja, Peey-Sei Kok, Yoland C Antill, et al.
The American Journal of Clinical Nutrition|May 5, 2023
Association of Protein Intake with Recurrence and Survival Following Primary Treatment of Ovarian CancerElizabeth A Johnston, Torukiri I Ibiebele, Michael L Friedlander, et al.
Nutrition and Cancer|October 10, 2024
Use of Dietary Supplements Before, During and After Treatment for Ovarian Cancer: Results from the Ovarian Cancer Prognosis and Lifestyle (OPAL) StudyRenhua Na, Christina M Nagle, Stefanie Bartsch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2014
Quality of life research in endometrial cancer: what is needed to advance progress in this disease site? Methodological considerations from the Gynecologic Cancer InterGroup Symptom Benefit Working Group brainstorming session, Leiden 2012Jessica N McAlpine, Elfriede Greimel, Lori A Brotto, et al.
The Medical Journal of Australia|November 19, 2013
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriersIan M Collins, Roger L Milne, Prue C Weideman, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Oncology|December 18, 2009
Oxaliplatin-induced lhermitte's phenomenon as a manifestation of severe generalized neurotoxicitySusanna B Park, Cindy S-Y Lin, Arun V Krishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Neuroprotection for oxaliplatin-induced neurotoxicity: what happened to objective assessment?Susanna B Park, David Goldstein, Cindy S-Y Lin, et al.
Plos One|April 16, 2011
Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicitySusanna B Park, Cindy S-Y Lin, Arun V Krishnan, et al.
Obstetrics and Gynecology|May 3, 2013
Primary surgical management with tailored adjuvant radiation for stage IB2 cervical cancerNeville F Hacker, Ellen L Barlow, James Scurry, et al.
Muscle & Nerve|February 16, 2011
Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathySusanna B Park, Cindy S-Y Lin, Arun V Krishnan, et al.
JNCI Cancer Spectrum|October 21, 2024
Impact of chemotherapy on patients with mismatch repair deficient advanced endometrial carcinomas-a meta-analysisAngelina Tjokrowidjaja, Peey-Sei Kok, Yoland C Antill, et al.
The American Journal of Clinical Nutrition|May 5, 2023
Association of Protein Intake with Recurrence and Survival Following Primary Treatment of Ovarian CancerElizabeth A Johnston, Torukiri I Ibiebele, Michael L Friedlander, et al.
Nutrition and Cancer|October 10, 2024
Use of Dietary Supplements Before, During and After Treatment for Ovarian Cancer: Results from the Ovarian Cancer Prognosis and Lifestyle (OPAL) StudyRenhua Na, Christina M Nagle, Stefanie Bartsch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2014
Quality of life research in endometrial cancer: what is needed to advance progress in this disease site? Methodological considerations from the Gynecologic Cancer InterGroup Symptom Benefit Working Group brainstorming session, Leiden 2012Jessica N McAlpine, Elfriede Greimel, Lori A Brotto, et al.
The Medical Journal of Australia|November 19, 2013
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriersIan M Collins, Roger L Milne, Prue C Weideman, et al.
Pageof 9